Home / Inspections / 752057

FDA Inspection 752057 — Aurolife Pharma, LLC

Aurolife Pharma, LLC — FEI 3005796917

The FDA completed an inspection of Aurolife Pharma, LLC on November 2, 2011 in Dayton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 2, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dayton, NJ (United States)

Facility

Other inspections at this facility

  • 1158258 (OAI Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1109452 (VAI Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1055912 (VAI Thu Jun 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 980107 (NAI Thu Jul 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 952634 (NAI Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources